• Sign up
  • Login

Scheme Profile

SBI Healthcare Opportunities Fund (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
3,611
Inception Date
31-12-2004
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 443.2899 (07-Jan-2025) / 335.066 (04-Jun-2024)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 420.10 ( -0.14) ( -0.03 %)
  • Benchmark
  • BSE Healthcare TRI
  • Fund Manager
  • Tanmaya Desai
  • Value of () 1,00,000 since inception
  • 19,01,757
  • Entry Load
  • NIL
  • Exit Load
  • 0.50% - If redeemed/switched out wihin 15 days from the date of allotment. Nil - If redeemed/switched out after 15 days from the date of allotment.
  • Expense Ratio (%)
  • 2.37
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 56.56 times
  • Portfolio P/B
  • 7.96 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.26

Risk Factors

  • Jenson's Alpha
  • 12.65
  • Standard Deviation
  • 4.31
  • Beta
  • 0.78
  • Sharpe
  • 1.06
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.11

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Mar 2025 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceutical Industries Ltd
  • Equity
  • 28,00,000
  • 13.45
  • Max Healthcare Institute Ltd
  • Equity
  • 22,00,000
  • 6.68
  • Divis Laboratories Ltd
  • Equity
  • 3,75,000
  • 6.00
  • Cipla Ltd
  • Equity
  • 12,00,000
  • 4.79
  • Lupin Ltd
  • Equity
  • 8,40,000
  • 4.72

Sector Top 5 Holdings

  [ As on 31 Mar 2025 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 1,47,80,115
  • 66.56
  • Healthcare
  • 1,08,00,000
  • 29.96
  • Chemicals
  • 14,00,000
  • 3.48

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD -4.09 -8.13 0 2.54 3,610.51
2024 41.92 34.92 10.35 8.12 3,628.03
2023 38.25 31.12 38.35 18.10 2,263.22
2022 -5.78 -9.58 -11.31 2.80 1,660.46
2021 19.03 17.96 20.57 21.69 1,942.51
2020 65.28 65.84 62.19 15.60 1,575.33
2019 -0.63 4.22 -3.06 13.79 926.47
2018 -9.90 -2.00 -5.45 6.67 1,045.43
2017 1.49 4.69 0.53 28.06 1,132.62
2016 -14.20 -12.31 -12.63 1.78 1,006.68

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Mar-2025 -6.16 -8.95 0 0 3,610.51
Dec-2024 3.75 1.62 0 0 3,628.03
Sep-2024 17.01 19.55 0 0 3,346.13
Jun-2024 3.29 3.29 0 0 2,760.05

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Quick links

Close